Bacterial transformation
consists of a complex series of interactions between transforming DNA and recipient cell components. The nature of the recipient cell is changed in such a way that transforming DNA is taken up and genes on it are expressed in recipient cells 1 On the other side of the paper disc also at a distance of 0.1 mm, 10 1e1
of 100 times diluted competent cells suspended in 100 1eg/ml of tryptophan solution was streaked.
Dilution of the competent cells was performed so that the number of transformants on one side became equal to that of total cells on the other side of the disc.
(Frequency of the transformation was 0.1 %.) DNA solution and cell suspension were carefully streaked on the agar plate so that they did not touch drug-containing discs.
After 20-hour incubation of the plates at 37°C, the distance between the center of the disc and the edge of any inhibited zone was measured in mms.
Localization
of the activity on a silica gel thin-layer chromatogram: A piece of tissue paper was laid on agar medium in a rectangular dish and a thin-layer plate was put on it. After the minutes, the thin-layer plate and the paper were removed. After DNA solution was streaked from the beginning to the top of the track of the plate, competent cells were then streaked.
Activities on the thin-layer chromatogram were detected by discontinuation of the growth of the transformed cells on agar medium.
Liquid transformation assay was conducted as follows: Forty lel of competent cell suspension were incubated with 20 hl of drug solution, 130 pl of transformation medium and 10 11 of DNA solution (200 pg/ml) at 37°C for 20 minutes.
An aliquot (20 hl) was taken and streaked on a synthetic agar plate.
For assaying antibacterial activity, the remaining incubation mixture was diluted 100-fold with transformation medium containing 100 hg/ml of tryptophan and 20 111 were streaked on a synthetic agar plate. Deoxycholate exerted the most drastic effect on transformation at the concentration used.
Azaserine (an inhibitor of de nove purine synthesis7), cationic detergent such as cetyltrimethylammonium bromide, colistin and gramicidin S (inhibitors of bacterial membrane7) had no specificity in their inhibitory activity against bacterial growth and transformation.
Although inhibitors of respiration such as antimycin A7) and oligomycin') did not inhibit both activities (Table 1) , inhibition of transformation was observed in an assay conducted in liquid medium at a concentration of 10 pg/ml (data not shown).
This limited survey indicates that the method employed is adequate to discriminate whether an agent inhibits transformation more effectively than bacterial growth or vice versa. From the inhibition pattern of drugs against bacterial growth and transformation, it was inferred that in nature there should be specific inhibitors of B. subtilis transformation without antibacterial activity.
In order to test this possibility, cultured broths of Streptomyces were tested for antibacterial and antitransformation activity. After examining 300 strains, one strain Streptomyces sp. 7725-CC1 was found to produce a potent inhibitor of transformation that has no activity against bacterial growth.
Isolation of Antraformin
An active principle found to be produced by Streptomyces sp. 7725-CC1 was named antraformin after its specific inhibitory effect on B. subtilis transformation.
Streptomyces sp. 7725-CC1 was inoculated from slant culture into 10 ml of a medium in a 30 ml test tube consisting of 1.5% soybean flour, 0.2% (NH4)2SO4, 2% soluble starch, 0.5% NaCI and 0.4%CaCO3 (pH 6.4 before autoclaving) and incubated by shaking for 3 days at 30°C. One ml of the resulting cell suspension was then inoculated into 100 ml of the same medium and grown in a long neck flask (500 ml) on a reciprocal shaker at 30°C for 48 hours.
Cultured broth (1.8 liter) was centrifuged to remove cell pellets and the supernatant was extracted twice with equal volumes of butanol. The aqueous phase was saved, brough to pH 2.0 with concentrated hydrochloric acid and again extracted twice with equal volumes of butanol.
The butanol extract was concentrated in vacuo to 4-5 ml, 100 ml of ethyl acetate was added and the resultant precipitate was discarded. To the supernatant was added an equal volume of water, and the ethyl acetate layer was discarded. The water layer was concentrated, neutralized with conc.NH4OH, two volumes of ethanol were added and the precipitate which formed was discarded. The ethanolic solution was concentrated to dryness and the residue was dissolved in 1 ml of butanol saturated with 0.01 N NH4OH. The solution (0.2 ml) was charged on an Avicel (microcrystalline cellulose) column (1.8 x 28.5 cm) which had been equilibrated with the same solvent used for the sample. Active fractions which were eluted with the solvent described above appeared in two peaks.
The first peak which eluted between 29 ml and 37 ml was contaminated with brown pigment and showed relatively less activity than the second peak (between 60 ml and 81 ml). Fractions with stronger activities of the second peak were collected and concentrated to dryness.
The resultant white material was dissolved in butanol saturated with water and purified by Sephadex LH-20 column (1.8 x 60 cm) chromatography using the same solvent system used for dissolving the material. Active fractions were eluted at about 0.4 column volume and each of them was chromatographed on silica gel thin-layer plates in order to examine purity (solvent system: butanol saturated with 0.01 N NH4OH).
Substances on the thin-layer plates were detected by heating the plates on which 10% sulfuric acid had been sprayed. Fractions that showed only one spot were collected, evaporated to dryness, and further dried under reduced pressure at 50°C overnight. On silica gel thinlayer chromatography, the Rf value of the substance thus obtained coincided with that of the biologically active spot (see methods) in the following solvent systems. Antraformin is a hygroscopic white powder. It is soluble in ethanol, butanol, methanol, pyridine, acetic acid, acetone, slightly soluble in water and insoluble in ethyl acetate, chloroform and benzene. The UV spectrum of antraformin, 2CH3OHmax 278 nm (E1%1cm59), is reproduced in Fig. 1 . Its infrared spectrum measured in nujol shows characteristic absorption at 3300 cm-1, 1730 cm-1 and 1250 cm-1 as shown in Fig. 2 .
Antraformin was subjected to mass spectroscopy analysis (electron impact method) in order to determine the molecular formula, since elementary analyses performed did not give satisfactory results. Thus a molecular weight of 279.1607 was obtained, from which a molecular formula of C14H21N3O3 (279.158292) was suggested for the compound. There was another possible molecular formula such as C19H21N1O1 (279.162314). However, since there were peaks such as C6H5N3O and C7H5N1O3 in the low field of the spectrum (data not shown), the former molecular formula was adopted. To the author's knowledge, a compound with the molecular formula and unique biological properties described above has not been reported so far. Although precise details of the transformation inhibition mechanism were not investigated in this study, antraformin has an attractive biological property and is expected to be a useful tool to investigate the mechanism of transformation.
